MOVANO INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.4845 USD | -2.91% |
|
-1.60% | -38.00% |
| 04-17 | Movano Inc. announced that it has received $24.128792 million in funding | CI |
| 04-04 | Transcript : Movano Inc., Q4 2023 Earnings Call, Apr 04, 2024 |
| Sales 2022 | - | Sales 2023 | - | Capitalization | 43.01M 3.44B |
|---|---|---|---|---|---|
| Net income 2022 | -30M -2.4B | Net income 2023 | -29M -2.32B | EV / Sales 2022 | - |
| Net cash position 2022 | 10.33M 827M | Net cash position 2023 | 5.89M 471M | EV / Sales 2023 | - |
| P/E ratio 2022 |
-1.42
x | P/E ratio 2023 |
-1.23
x | Employees | 30 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 84.35% |
More Fundamentals
* Assessed data
More news
Latest transcript on Movano Inc.
More press releases
| 1 day | -2.91% | ||
| 1 week | -1.60% | ||
| Current month | +17.85% | ||
| 1 month | +21.46% | ||
| 3 months | -23.42% | ||
| 6 months | -39.44% | ||
| Current year | -38.00% |
1 week
0.46
0.50
1 month
0.400.59
Current year
0.370.85
1 year
0.371.50
3 years
0.375.76
5 years
0.377.45
10 years
0.377.45
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 63 | 30/11/20 | |
Michael Leabman
FOU | Founder | 51 | 31/12/17 |
Jeremy Cogan
DFI | Director of Finance/CFO | 55 | 30/04/19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 14/04/22 | |
Emily Fairbairn
CHM | Chairman | 62 | 31/12/17 |
Michael Leabman
FOU | Founder | 51 | 31/12/17 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 0.475 | -1.96% | 33,426 |
| 25/04/24 | 0.4845 | -2.91% | 13,979 |
| 24/04/24 | 0.499 | +3.08% | 10,382 |
| 23/04/24 | 0.4841 | +3.22% | 4,721 |
| 22/04/24 | 0.469 | -4.75% | 69,889 |
End-of-day quote Nasdaq, April 24, 2024
More quotes
Movano Inc., doing business as Movano Health, is focused on developing a platform to deliver healthcare solutions to bring medical-grade, data to the forefront of consumer health devices. The Company's product in development is the Evie Ring, which is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one's health, which includes resting heart rate, heart rate variability (HRV), blood oxygen saturation (SpO2), respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. In addition to the Evie Ring, the Company is also developing System-on-a-Chip (SoC) designed specifically for blood pressure or continuous glucose monitoring (CGM) systems.
Calendar
08/05/2024
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -38.00% | 46.66M | |
| +8.07% | 219B | |
| +6.59% | 183B | |
| +11.26% | 133B | |
| +26.57% | 108B | |
| +0.65% | 63.06B | |
| +13.35% | 52.02B | |
| -0.62% | 48.2B | |
| -0.93% | 40.37B | |
| +11.54% | 39.35B |
- Stock Market
- Equities
- MOVE Stock
